English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Atlas Point Media

Patient Daily | Apr 23, 2026

Health policy advocate raises concerns about 340B program's impact on patients

Trending

+ Regulatory
Patient Daily | Apr 16, 2026

Health Analyst: Abuse of 340b drug discount program ‘leaves patients stuck in the middle’

+ Pharmaceuticals
Patient Daily | Apr 19, 2026

Insmed ends skin disease drug development after trial results fall short

+ Pharmaceuticals
Patient Daily | Apr 19, 2026

Roche and C4 Therapeutics announce new molecular glue partnership worth up to $1 billion

+ Pharmaceuticals
Patient Daily | Apr 19, 2026

Novavax shareholder plans to oppose CEO pay and board at upcoming meeting



Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily